Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
47
pubmed:dateCreated
2009-11-2
pubmed:databankReference
pubmed:abstractText
Dosage-sparing strategies, adjuvants and alternative substrates for vaccine production are being explored for influenza vaccine development. We assessed the safety and immunogenicity of a Vero cell culture-grown inactivated whole virus influenza A/H5N1 vaccine with or without aluminum hydroxide adjuvant [Al(OH)(3)] in healthy young adults. Vaccines were well tolerated, but injection site discomfort was more frequent in groups receiving Al(OH)(3). Dose-related increases in serum antibody levels were observed. Neutralizing antibody titers varied significantly when tested by two different laboratories. Al(OH)(3) did not enhance HAI or neutralizing antibody responses, and contributed to increased injection site pain. Because influenza antibody titers vary significantly between different laboratories, international standardization of assays is warranted.
pubmed:grant
http://linkedlifedata.com/resource/pubmed/grant/M01 RR-00070, http://linkedlifedata.com/resource/pubmed/grant/M01 RR-00095, http://linkedlifedata.com/resource/pubmed/grant/M01 RR000070-38, http://linkedlifedata.com/resource/pubmed/grant/M01 RR000095-41, http://linkedlifedata.com/resource/pubmed/grant/M01 RR165001, http://linkedlifedata.com/resource/pubmed/grant/N01 AI025461, http://linkedlifedata.com/resource/pubmed/grant/N01 AI025462, http://linkedlifedata.com/resource/pubmed/grant/N01 AI025463, http://linkedlifedata.com/resource/pubmed/grant/N01 AI025465, http://linkedlifedata.com/resource/pubmed/grant/N01-AI-25461, http://linkedlifedata.com/resource/pubmed/grant/N01-AI-25462, http://linkedlifedata.com/resource/pubmed/grant/N01-AI-25463, http://linkedlifedata.com/resource/pubmed/grant/N01-AI-25465
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19773098-11166898, http://linkedlifedata.com/resource/pubmed/commentcorrection/19773098-11425416, http://linkedlifedata.com/resource/pubmed/commentcorrection/19773098-15163495, http://linkedlifedata.com/resource/pubmed/commentcorrection/19773098-15163505, http://linkedlifedata.com/resource/pubmed/commentcorrection/19773098-16571878, http://linkedlifedata.com/resource/pubmed/commentcorrection/19773098-16641963, http://linkedlifedata.com/resource/pubmed/commentcorrection/19773098-16714186, http://linkedlifedata.com/resource/pubmed/commentcorrection/19773098-16980114, http://linkedlifedata.com/resource/pubmed/commentcorrection/19773098-17029131, http://linkedlifedata.com/resource/pubmed/commentcorrection/19773098-17412461, http://linkedlifedata.com/resource/pubmed/commentcorrection/19773098-17644429, http://linkedlifedata.com/resource/pubmed/commentcorrection/19773098-17707753, http://linkedlifedata.com/resource/pubmed/commentcorrection/19773098-18044056, http://linkedlifedata.com/resource/pubmed/commentcorrection/19773098-18260764, http://linkedlifedata.com/resource/pubmed/commentcorrection/19773098-18550874, http://linkedlifedata.com/resource/pubmed/commentcorrection/19773098-18599164, http://linkedlifedata.com/resource/pubmed/commentcorrection/19773098-18729777, http://linkedlifedata.com/resource/pubmed/commentcorrection/19773098-18808338, http://linkedlifedata.com/resource/pubmed/commentcorrection/19773098-19453427, http://linkedlifedata.com/resource/pubmed/commentcorrection/19773098-606763, http://linkedlifedata.com/resource/pubmed/commentcorrection/19773098-606798, http://linkedlifedata.com/resource/pubmed/commentcorrection/19773098-6353529
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1873-2518
pubmed:author
pubmed:issnType
Electronic
pubmed:day
5
pubmed:volume
27
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
6642-8
pubmed:dateRevised
2011-7-20
pubmed:meshHeading
pubmed-meshheading:19773098-Adjuvants, Immunologic, pubmed-meshheading:19773098-Adolescent, pubmed-meshheading:19773098-Adult, pubmed-meshheading:19773098-Aluminum Hydroxide, pubmed-meshheading:19773098-Animals, pubmed-meshheading:19773098-Antibodies, Viral, pubmed-meshheading:19773098-Cercopithecus aethiops, pubmed-meshheading:19773098-Dose-Response Relationship, Immunologic, pubmed-meshheading:19773098-Double-Blind Method, pubmed-meshheading:19773098-Female, pubmed-meshheading:19773098-Hemagglutination Inhibition Tests, pubmed-meshheading:19773098-Humans, pubmed-meshheading:19773098-Influenza, Human, pubmed-meshheading:19773098-Influenza A Virus, H5N1 Subtype, pubmed-meshheading:19773098-Influenza Vaccines, pubmed-meshheading:19773098-Male, pubmed-meshheading:19773098-Neutralization Tests, pubmed-meshheading:19773098-Vero Cells, pubmed-meshheading:19773098-Young Adult
pubmed:year
2009
pubmed:articleTitle
Safety and immunogenicity of inactivated, Vero cell culture-derived whole virus influenza A/H5N1 vaccine given alone or with aluminum hydroxide adjuvant in healthy adults.
pubmed:affiliation
Baylor College of Medicine Vaccine Research Center, Houston, TX 77030, USA. wkeitel@bcm.edu
More...